Why freelance network?

Why Freelance?

Because it allows us to get together professionals with extensive experience at competitive pricing.

Why a Network?

Although a professional may have extensive experience and be an expert in his area, the best results are achieved working in a team.

How the network works?

The coordinator and the expert in the area, working as a team, review each work request. Only one budget for the client. A single contact person. A team at the service of the sponsor.

Network professionals have knowledge of the Efficacy ICH’s guidelines on clinical trials (E1 to E18), from basic Good Clinical Practice (GCP) European regulatory requirements to adaptive sample size calculations. We have a group of advisors for more specific topics as Pharmacogenetics (ICH-E15) or Genomic Sampling Methodologies (ICH-E18).

Who contract?

You always contract a named professional that will be your direct contact. There will be no intermediary between your work and the person who does.

Is it a new company?

No, it’s not a CRO or company or anything like that. It is a network of professionals working on their own, coordinating efforts and work to give the best of themselves.


What are the benefits of working with the Network?

Quality, the first condition to be part of the Network is to be a senior in your speciality. We do not have training or continuous turn over of professionals.

Flexibility, our working procedures are your procedures. We have no others. We work only with what you need. We do not have others.

Price, we do not have accounting, management, administration, human resources, and other essential departments in a company, but we do not need them in our network. This allows us to work at a lower cost than any other company.

Who are our customers?

We work for pharmaceutical companies, CROs and associations of investigators.

What projects are we working on?

We are not afraid of big studies, but today our network is designed for small, national or international projects.

From Phase II clinical trials to Observational and Epidemilogical Studies according the international and national regulations.

KOL: We have an extensive network of Key Opinion Leaders (KOL) of different therapeutic specialties with whom we collaborate for specific projects either in the design of study proposals and implementation of clinical research projects. To work with KOL we proposed various options together with the sponsor project by project.

What is different?

We are not a big or small CRO, but we work for both small companies and Big Pharma as well as for independent investigators. What makes us different is the proximity to the sponsors and adaptation to their needs.


Recent publish manuscripts with collaboration of Trialance team

    • Efficacy and Safety of Ciprofloxacin Plus Fluocinolone in Otitis Media With Tympanostomy Tubes in Pediatric Patients: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2016 Dec 22. doi: 10.1001/jamaoto.2016.3537.
    • Monitoring Ingenol Mebutate Gel Treatment of Actinic Keratoses by Reflectance ConfocalMicroscopy. Acta Derm Venereol. 2017 Jan 17. doi: 10.2340/00015555-2607.
    • When the healthcare does not follow the evidence: The case of the lack of early intervention programs for psychosis in Spain. Rev Psiquiatr Salud Ment. 2017 Feb 8. pii: S1888-9891(17)30016-2. doi: 10.1016/j.rpsm.2017.01.001.
    • Long acting Aripiprazole in Comorbid Bipolar Disorder and Borderline Personality Disorder and Substance Abuse. J Clin Psychopharmacol. 2017 Apr;37(2):266-267. doi: 10.1097/JCP.0000000000000653.
    • Tear cytokine profile of glaucoma patients treated with preservative-free or preservedlatanoprost. Ocul Surf. 2017 Mar 22. pii: S1542-0124(16)30269-5. doi: 10.1016/j.jtos.2017.03.004.
    • Ulipristal Acetate in Myomectomy Optimization in an Infertile Patient with Giant Myomas, Case Rep Med. 2016;2016:5135780. doi: 10.1155/2016/5135780. Epub 2016 Aug 10.
    • Treatment with ulipristal acetate (Esmya(®)) and plasma levels of tacrolimus: a case report. Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:337-8. doi: 10.1016/j.ejogrb.2016.05.014. Epub 2016 May 20.

Ongoing clinical trials in different areas

Medical device, dermatology, oncology, food supplements, auto immune diseases, cardiology and gynecology


Customers 2016-2017


Trialance in press

El Periódico de Catalunya